FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

414091005: Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet (clinical drug)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Feb 2022. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    2531221018 Emtricitabine 200mg/tenofovir 300mg tablet (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    2534726011 Emtricitabine 200mg/tenofovir 300mg tablet en Synonym Inactive Only initial character case insensitive SNOMED CT core module
    2537510019 Emtricitabine 200mg/tenofovir disoproxil fumarate 300mg tablet en Synonym Inactive Only initial character case insensitive SNOMED CT core module
    2545904013 Emtricitabine 200mg/tenofovir 136mg tablet (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    2548166010 Emtricitabine 200mg/tenofovir 136mg tablet en Synonym Inactive Only initial character case insensitive SNOMED CT core module
    2553555016 Emtricitabine 200mg/tenofovir disoproxil 245mg tablet en Synonym Inactive Only initial character case insensitive SNOMED CT core module
    3486946016 Product containing emtricitabine 200 mg and tenofovir 136 mg/1 each oral tablet (clinical drug) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
    3495360015 Product containing emtricitabine 200 mg and tenofovir 136 mg/1 each oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
    3502010019 Emtricitabine 200 mg and tenofovir 136 mg oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
    3570120012 Product containing only emtricitabine 200 mg and tenofovir 136 mg/1 each oral tablet (clinical drug) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
    3570121011 Product containing only emtricitabine 200 mg and tenofovir 136 mg/1 each oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
    3678523015 Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3678524014 Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
    3678525010 Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
    108401701000001116 Emtricitabine 200 mg and tenofovir 136 mg oral tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Is a Product containing emtricitabine and tenofovir false Inferred relationship Existential restriction modifier
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has active ingredient Emtricitabine false Inferred relationship Existential restriction modifier
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has active ingredient Tenofovir disoproxil fumarate false Inferred relationship Existential restriction modifier
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Is a Product manufactured as oral dose form false Inferred relationship Existential restriction modifier
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Is a Product containing emtricitabine and tenofovir in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has active ingredient Emtricitabine false Inferred relationship Existential restriction modifier 1
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has basis of strength substance Emtricitabine false Inferred relationship Existential restriction modifier 1
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has presentation strength numerator value 200 false Inferred relationship Existential restriction modifier 1
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 1
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet false Inferred relationship Existential restriction modifier 1
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has active ingredient Tenofovir disoproxil fumarate false Inferred relationship Existential restriction modifier 2
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has basis of strength substance Tenofovir disoproxil fumarate false Inferred relationship Existential restriction modifier 2
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has presentation strength numerator value 136 false Inferred relationship Existential restriction modifier 2
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 2
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet false Inferred relationship Existential restriction modifier 2
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has basis of strength substance Tenofovir disoproxil fumarate false Inferred relationship Existential restriction modifier 1
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has presentation strength numerator value 136 false Inferred relationship Existential restriction modifier 1
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has basis of strength substance Emtricitabine false Inferred relationship Existential restriction modifier 2
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has presentation strength numerator value 200 false Inferred relationship Existential restriction modifier 2
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has precise active ingredient Emtricitabine false Inferred relationship Existential restriction modifier 2
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Has precise active ingredient Tenofovir disoproxil fumarate false Inferred relationship Existential restriction modifier 1
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Is a Product containing only emtricitabine and tenofovir in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Plays role Antiretroviral therapeutic role false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start